Saturday, July 11, 2026

Drug profile · INN

donepezil

donepezil (ARICEPT) is a acetylcholinesterase inhibitor. Associated with Pfizer Australia Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 11
News articles 0
Drug details — donepezil

Quick answer

donepezil (ARICEPT) is a acetylcholinesterase inhibitor. Associated with Pfizer Australia Pty Ltd.

Key facts

INN donepezil
Brand ARICEPT
Mechanism Acetylcholinesterase inhibitor

Mechanism of action

Acetylcholinesterase inhibitor

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. Donepezil Phase 3 · Universal Integrated · Osteoarthritis
  2. D22-P020 Phase 2 · PARItec · Anorexia nervosa
  3. Donepezil Hydrochloride Phase 2 · Sun Yat-sen Memorial · Radiation Injuries
  4. High-dose donepezil Phase 2 · BRIGHT MINDS BIOSCIENCES · Cocaine Use Disorders
  5. donepezil Phase 2 · Chinese Academy of · Cognitive Impairment
  6. Donepezil Phase 1 · Teva Pharma · Healthy
  7. Donepezil Dihydroxynaphthalate for Injection Phase 1 · Shanghai University of · Alzheimer Disease
  8. Donepezil Hydrochloride Phase 1 · Teva Pharma · Healthy

Frequently asked questions

What is donepezil?

donepezil (ARICEPT) is a acetylcholinesterase inhibitor. Associated with Pfizer Australia Pty Ltd.

What is the brand name for donepezil?

ARICEPT is a marketed brand name for donepezil. Check FDA Drugs@FDA for the current US label holder and prescribing information.